Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · IEX Real-Time Price · USD
3.270
-0.080 (-2.39%)
At close: Apr 17, 2024, 4:00 PM
3.570
+0.300 (9.17%)
Pre-market: Apr 18, 2024, 4:40 AM EDT
Tempest Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for TPST stock have an average target of 22.25, with a low estimate of 13 and a high estimate of 47. The average target predicts an increase of 580.43% from the current stock price of 3.27.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for TPST stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 2 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 4 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $47 | Strong Buy | Reiterates | $47 | +1,337.31% | Mar 20, 2024 |
| Scotiabank | Scotiabank | Buy Initiates $13 | Buy | Initiates | $13 | +297.55% | Mar 14, 2024 |
| Scotiabank | Scotiabank | Buy Initiates $13 | Buy | Initiates | $13 | +297.55% | Mar 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $47 | Strong Buy | Maintains | $47 | +1,337.31% | Mar 12, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +358.72% | Feb 8, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.44
from -1.91
EPS Next Year
-1.56
from -1.44
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 56.2M | 170.3M | 600.6M |
| Avg | n/a | n/a | 13.7M | 94.5M | 583.4M |
| Low | n/a | n/a | n/a | n/a | 560.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 1,147.0% | 535.8% |
| Avg | - | - | - | 591.6% | 517.6% |
| Low | - | - | - | - | 493.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.97 | -0.68 | -0.65 | 1.28 | 6.42 |
| Avg | -1.44 | -1.56 | -1.95 | -1.02 | 6.23 |
| Low | -1.83 | -2.53 | -3.80 | -3.85 | 5.99 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.